Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to the Annual General Meeting in GARO Aktiebolag (publ)

The shareholders of GARO Aktiebolag (publ) (”GARO” or the ”Company”), Reg. No. 556051-7772, are hereby invited to attend the Annual General Meeting (the “AGM”) to be held at 5 p.m. CEST on 11 May 2023 at Gnosjöandans Kunskapscenter, at the address Fritidsvägen 4, Gnosjö, Sweden. Registration will commence at 4.30 p.m. CEST.A. RIGHT TO PARTICIPATE IN THE AGMA person who wishes to participate in the AGM must: firstly, be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances on 3 May 2023, and secondly, notify

Citycon publishes 2022 Sustainability Accounts – again named European Climate Leader by Financial Times and led by Lippulaiva, world’s first centre to achieve Smart Building Gold certificate

CITYCON OYJ Corporate Press Release 31 March 2023 at 9:00 hours Citycon Oyj’s Sustainability Accounts for 2022 have been published today. Once again, Citycon was named one of Europe’s Climate Leaders by Financial Times and German research company Statista. Significant and documented progress towards the company’s ambitious targets for areas such as emissions reductions, energy consumption and accessibility were achieved during the year, in addition to the opening of Lippulaiva in Espoo, Finland, a shining example of the Citycon’s commitment to sustainability. Lippulaiva houses

Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares

(Stockholm, Sweden, March 31, 2023) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of March 31, 2023, the total number of issued shares of common stock  is 90,717,624 of which 85,829,804 shares are outstanding.Autoliv retired 450,159 shares of common stock that had been repurchased during the quarter which resulted in a decrease in the issued shares. The Company now has a total of 90,717,624 issued shares of common stock of which 85,829,804 shares are outstanding. Each share of outstanding common stock is entitled

Elkem curtails production capacity in Norway to accelerate maintenance

Elkem has decided to partially curtail its production in Norway by temporarily shutting down two furnaces – one in Thamshavn and one in Rana. The decision will have no impact on customers or employees.“We have decided to utilise a period with somewhat lower sales to bring forward planned maintenance and improvement work to position for the future. This will enable lower production costs once stronger market conditions return,” says Elkem’s senior vice president for Silicon Products, Inge A. Grubben-Strømnes. Elkem will invest a total of around NOK 200 million in maintenance and

Eisai publishes additional detailed analyses from lecanemab phase 2b study

Stockholm, March 31, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today the publication of additional detailed analyses from the phase 2b clinical study (Study 201), evaluating the efficacy and safety of lecanemab for mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD). Lecanemab is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibrils) and insoluble forms of amyloid beta (Aβ). The data was published in three articles in peer-reviewed journals;

Change in the number of shares and votes in Tele2

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announced that the total number of shares and votes in Tele2 have increased by 1,200,000 shares and votes, respectivelyThe change relates to 1,200,000 class C shares issued in March 2023.   The purpose of the share issue and the repurchase is to enable the future delivery of class B shares to senior executives and other key employees participating in Tele2’s retention and performance-based incentive programs.   As of 31 March 2023, the total number of shares in Tele2 amounts to 696,221,597 of which 22,551,

Safello Group AB Publishes Annual Report for 2022

Stockholm, 31 March 2023 | Today, Safello Group AB (“Safello”) publishes the company’s annual report for 2022. The annual report is available in Swedish, with an English translation, on the company’s website: safello.com/ir .  “2022 was a challenging year for the crypto industry as well as the financial industry as a whole. Despite the turmoil in the market we have managed to steer Safello towards profitability by cutting costs and keeping a strict focus on product development and innovation. Whereas the full year shows a negative bottom line,

Increased number of shares and voting rights in Catena Media plc

Catena Media plc announces that the number of shares and voting rights in the company has increased by 6,663,913 due to the exercise of Catena Media’s warrants (CTM TO1) during the 12th  warrant exercise period that followed publication of the Year-end Report for the fourth quarter of 2022. As announced on 7 March 2023, 6,663,913 warrants were used to subscribe for the same number of new ordinary shares in Catena Media during the 12th warrant exercise period. The new shares were then registered with the Maltese authorities. As of 31 March 2023, the last trading day of the month, the

Hansa Biopharma completes enrollment in phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS)

Lund, Sweden, 31 March 2023. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced it has completed enrollment in its phase 2 study of imlifidase in Guillain-Barré Syndrome (GBS). Top-line data is expected to be shared during the second half of 2023. Søren Tulstrup, President and CEO, Hansa Biopharma said, “This phase 2 study of imlifidase in GBS is an important next step in understanding the role of our antibody-cleaving enzyme technology in treating rare immunologic conditions. We remain fully committed to

LKAB Launches Largest International Recruitment Drive in Houten, Netherlands

Swedish global mining and minerals group LKAB embarks on its most extensive international recruitment campaign to date at the Emigration Expo in Houten, Netherlands. The company seeks to attract Dutch professionals to new career and life opportunities in Arctic Sweden, fueled by a green industrial boom and a thriving job market in the region."As we undergo the most significant transition in our 130-year history, we require the brightest and most dedicated minds to join us. The well-educated, multilingual, and entrepreneurial nature of the Dutch makes the Netherlands the ideal starting point

Paulig’s result in 2022: Revenue exceeded EUR 1.1 billion, but profitability declined in an exceptional year

In 2022, Paulig’s revenue grew by 14 per cent and exceeded EUR 1 billion for the first time ever.  This revenue growth was driven by price increases and the acquisition of Liven, an innovative Spanish-based snacks company. However, the global increase in the cost of raw materials, energy, transportation and other costs – further accelerated by the war in Ukraine – resulted in weakened operative profitability. Comparable operating profit was EUR 44.2 million compared to EUR 95.3 million in 2021. The biggest factor affecting the decline in comparable operating profit was the

Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections

This press release or the merger does not constitute an offer, either directly or indirectly in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States, or in any other jurisdiction where such offer under the laws and regulations of such relevant jurisdiction would be prohibited by applicable law. Shareholders who are not resident in Sweden and who wish to accept the proposed merger consideration must carry out closer investigations regarding the applicable legislation and possible tax consequences. The two pharmaceutical companies Hamlet

Notice of Annual General Meeting in Karnov Group AB (publ)

The shareholders of Karnov Group AB (publ), reg. no. 559016-9016 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held at 09.00 a.m., on Wednesday 10 May 2023, at Cirio Advokatbyrå, Mäster Samuelsgatan 20, in Stockholm. The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to Chapter 7, Section 4 a of the Swedish Companies Act and § 13 in the Company’s Articles of Associations. Therefore, shareholders may choose to exercise their voting rights at the AGM by

Change in number of shares and votes in Viaplay Group

Viaplay Group AB (publ) (“Viaplay Group”) today announces that the total number of shares and votes in Viaplay Group has increased by 680,000 shares and votes respectively. The change relates to 680,000 class C shares issued in March 2023. As of 31 March 2023, the total number of shares in Viaplay Group amounts to 79,122,244 of which 531,536 are class A shares with 10 votes each, 77,701,208 are class B shares with one vote each and 889,500 are class C shares with one vote each. The total number of votes in Viaplay Group amounts to 83,906,068. The total number of votes in Viaplay

Viking Line Abp: Invitation to AGM

Viking Line Abp                    NOTICE TO GENERAL MEETING              31.3.2023, 9.00 AM INVITATION TO THE ANNUAL GENERAL MEETING The shareholders in Viking Line Abp are invited to the Annual General Meeting, which will be held at 12.00 noon on Thursday, April 27, 2023, at Alandica Culture and Congress, Strandgatan 33, Mariehamn, Åland.The reception of persons who have registered for the Meeting and the distribution of voting tickets will begin at 11.00 a.m. A. The items on the agenda of the Annual General Meeting The Annual General Meeting will deal with the following

Hexagon publishes the Annual Report and Sustainability Report 2022

Hexagon's Annual Report 2022 and separate Sustainability Report is now available at Hexagon's website hexagon.com . Hexagon intends to solely distribute the reports digitally. If you however still want to receive a printed copy of the Annual Report, please contact Hexagon at mailorderservice@hexagon.com or call +46 (0)8 601 26 20.As previously communicated, Hexagon's Annual General Meeting will be held at 16:00 CET on Tuesday 2 May 2023, at IVA Conference Center, Grev Turegatan 16, Stockholm. Notification

Millennium Technology Prize opens its nomination period at the 20-year milestone of the Prize

One of the world’s leading technology prizes, Millennium Technology Prize, will be awarded for the next time on 30 October 2024, celebrating the 20th anniversary of the Prize. The global call for nominations of breakthrough innovations will be open between 1 April and 31 October 2023. Nominations can now be made by individuals, companies, and other organizations in all fields of technology except military technology*.Millennium Technology Prize is the pre-eminent one-million-euro award focused on technological innovations for a better life. This includes work that improves human well-being,

Wärtsilä Cargo Handling and Fuel Gas Supply systems continue to be the choice for ethane carriers

Wärtsilä Corporation, Press release, 31 March 2023 at 9.00 AM EESTTechnology group Wärtsilä has again been contracted by the Hyundai Heavy Industries (HHI) shipyard to supply the Cargo Handling and integrated Fuel Gas Supply systems  for Very Large Ethane Carrier (VLEC) vessels. This latest order, booked by Wärtsilä in Q1, 2023, is for two VLECs being built for Japanese ship owner Iino Line. It follows a series of ongoing deliveries of similar newbuild VLEC vessels at HHI. Wärtsilä has had a long-standing relationship with HHI,

Peab receives road contracts for 360 million Swedish kronor

Peab has received two new operation contracts for road maintenance from the Swedish Transport Administration. In total Peab will maintain around 3,000 kilometers of state roads over the next four years with an extension option for another two years. The cumulative worth of the contracts is SEK 360 million.Sweden’s national road network is divided into geographic areas consisting of 550 to 1,750 kilometers of roads. Peab has been awarded contracts for basic maintenance of the road networks in Strömsund and Tingsryd. The Swedish Transport Administration’s road contracts for these operation

Notice to Annual General Meeting in Probi AB (publ)

The shareholders of Probi AB (publ), reg. no. 556417-7540, are hereby officially convened to the Annual General Meeting (“AGM”) which will be held on 4 May 2023 at 3:00 p.m. at Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden.   The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the provisions in Probi’s Articles of Association.   Right to participate, notification of participation and postal voting A shareholder who wishes to attend the meeting room or who wishes to

Annual Report 2022

31 March 2023 Company announcement no. 66 Today, SGL International A/S has published its Annual Report for 2022, including full year results for SGLT Holding II LP. SGLT Holding (SGLT Holding II LP) · For SGLT Holding, the full year 2022 revenue was USD 3,506m versus USD 2,274m for full year 2021; corresponding to growth of 54%. Revenue increases throughout the year were primarily driven by a mix of increase in activity levels, both through increased activity and larger share of wallet with new and existing customers. Increase in activities for acquisitions also contributed. The

Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections

This press release or the merger does not constitute an offer, either directly or indirectly in Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or the United States, or in any other jurisdiction where such offer under the laws and regulations of such relevant jurisdiction would be prohibited by applicable law. Shareholders who are not resident in Sweden and who wish to accept the proposed merger consideration must carry out closer investigations regarding the applicable legislation and possible tax consequences. The two pharmaceutical companies Hamlet

There are no items matching the current filter
There are no more items matching the current filter
Back to top